179 related articles for article (PubMed ID: 32839829)
1. Immunogenic necroptosis in the anti-tumor photodynamic action of BAM-SiPc, a silicon(IV) phthalocyanine-based photosensitizer.
Zhang Y; Cheung YK; Ng DKP; Fong WP
Cancer Immunol Immunother; 2021 Feb; 70(2):485-495. PubMed ID: 32839829
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model.
Yeung HY; Lo PC; Ng DK; Fong WP
Cell Mol Immunol; 2017 Feb; 14(2):223-234. PubMed ID: 26388236
[TBL] [Abstract][Full Text] [Related]
3. Antitumor immunity induced by the photodynamic action of BAM-SiPc, a silicon (IV) phthalocyanine photosensitizer.
Zhang Y; Ng DKP; Fong WP
Cell Mol Immunol; 2019 Jul; 16(7):676-678. PubMed ID: 31076728
[No Abstract] [Full Text] [Related]
4. Photodynamic activity of BAM-SiPc, an unsymmetrical bisamino silicon(IV) phthalocyanine, in tumour-bearing nude mice.
Leung SC; Lo PC; Ng DK; Liu WK; Fung KP; Fong WP
Br J Pharmacol; 2008 May; 154(1):4-12. PubMed ID: 18332853
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells.
Azizuddin K; Kalka K; Chiu SM; Ahmad N; Mukhtar H; Separovic D
Int J Oncol; 2001 Feb; 18(2):411-5. PubMed ID: 11172611
[TBL] [Abstract][Full Text] [Related]
6. BAM-SiPc, a novel agent for photodynamic therapy, induces apoptosis in human hepatocarcinoma HepG2 cells by a direct mitochondrial action.
Lai JC; Lo PC; Ng DK; Ko WH; Leung SC; Fung KP; Fong WP
Cancer Biol Ther; 2006 Apr; 5(4):413-8. PubMed ID: 16481739
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effects of silicon phthalocyanine photodynamic therapy.
Reddan JC; Anderson CY; Xu H; Hrabovsky S; Freye K; Fairchild R; Tubesing KA; Elmets CA
Photochem Photobiol; 1999 Jul; 70(1):72-7. PubMed ID: 10420845
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
9. Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.
Master AM; Livingston M; Oleinick NL; Sen Gupta A
Mol Pharm; 2012 Aug; 9(8):2331-8. PubMed ID: 22775587
[TBL] [Abstract][Full Text] [Related]
10. Conjugate of biotin with silicon(IV) phthalocyanine for tumor-targeting photodynamic therapy.
Li K; Qiu L; Liu Q; Lv G; Zhao X; Wang S; Lin J
J Photochem Photobiol B; 2017 Sep; 174():243-250. PubMed ID: 28802175
[TBL] [Abstract][Full Text] [Related]
11. Photosensitizer IR700DX-6T- and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune responses during treatment of pancreatic cancer.
Zhang D; Xie Q; Liu Y; Li Z; Li H; Li S; Li Z; Cui J; Su M; Jiang X; Xue P; Bai M
Pharmacol Res; 2021 Oct; 172():105811. PubMed ID: 34390852
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.
Whitacre CM; Feyes DK; Satoh T; Grossmann J; Mulvihill JW; Mukhtar H; Oleinick NL
Clin Cancer Res; 2000 May; 6(5):2021-7. PubMed ID: 10815928
[TBL] [Abstract][Full Text] [Related]
13. A biotin receptor-targeted silicon(IV) phthalocyanine for in vivo tumor imaging and photodynamic therapy.
Li K; Dong W; Liu Q; Lv G; Xie M; Sun X; Qiu L; Lin J
J Photochem Photobiol B; 2019 Jan; 190():1-7. PubMed ID: 30453160
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic inactivation of Candida albicans by BAM-SiPc.
So CW; Tsang PW; Lo PC; Seneviratne CJ; Samaranayake LP; Fong WP
Mycoses; 2010 May; 53(3):215-20. PubMed ID: 19298354
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy effect of morpholinium containing silicon (IV) phthalocyanine on HCT-116 cells.
Yalçın CÖ; Barut B; Barut EN; Demirbaş Ü; Dinçer T; Engin S; Özel A; Sena Sezen F
Photodiagnosis Photodyn Ther; 2020 Dec; 32():101975. PubMed ID: 32835884
[TBL] [Abstract][Full Text] [Related]
16. Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck.
Werning JW; Stepnick DW; Jafri A; Megerian CA; Antunez AR; Zaidi SI
Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):783-9. PubMed ID: 7598858
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of novel Schiff base-silicon (IV) phthalocyanine complex for photodynamic therapy of breast cancer cell lines.
Sarı C; Değirmencioğlu İ; Eyüpoğlu FC
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103504. PubMed ID: 36907257
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhetinic Acid-Modified Silicon Phthalocyanine for Liver Cancer-Targeted Photodynamic Therapy.
Kim J; Lee S; Na K
Biomacromolecules; 2021 Feb; 22(2):811-822. PubMed ID: 33356155
[TBL] [Abstract][Full Text] [Related]
19. Killing efficacy of a new silicon phthalocyanine in human melanoma cells treated with photodynamic therapy by early activation of mitochondrion-mediated apoptosis.
Barge J; Decréau R; Julliard M; Hubaud JC; Sabatier AS; Grob JJ; Verrando P
Exp Dermatol; 2004 Jan; 13(1):33-44. PubMed ID: 15009114
[TBL] [Abstract][Full Text] [Related]
20. Non-canonical anti-cancer, anti-metastatic, anti-angiogenic and immunomodulatory PDT potentials of water soluble phthalocyanine derivatives with imidazole groups and their intracellular mechanism of action.
Ayaz F; Yetkin D; Yüzer A; Demircioğlu K; Ince M
Photodiagnosis Photodyn Ther; 2022 Sep; 39():103035. PubMed ID: 35905830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
